CompanyIntelligence | Immunomedics, Inc.

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$36	Subscribers Preview	2004	C a D W a L a D E R	Immunomedics, Inc.	Cadwalader, Wickersham & Taft
$43	Subscribers	2004	Common Stock Purchase Warrant	Amgen; Immunomedics	Heller Ehrman
$50	Subscribers Preview	2001	Development and License Agreement	Amgen, Inc.	Immunomedics, Inc.
$47	Subscribers Preview	2007	Employment Agreement	Immunomedics, Inc.
$40	Subscribers	2003	Immunomedics in Discussions to Regain Development Rights from Amgen For Epratuzumab	Amgen, Inc.	Immunomedics, Inc.
$38	Subscribers	2004	Immunomedics Regains North American Development Rights from Amgen for Epratuzumab	Amgen, Inc.	Immunomedics, Inc.
$84	Subscribers Preview	2004	Indenture	Immunomedics, Inc.	Bank of New York
$34	Subscribers	2004	Independent Accountants Consent	Immunomedics, Inc.
$32	Subscribers	2003	Independent Accountants Consent	Immunomedics, Inc.
$39	Subscribers Preview	2000	King Pharmaceuticals Announces Management Appointments Following Merger with Jones Pharma	Immunomedics, Inc.	King Pharmaceuticals Inc.
$36	Subscribers	2003	MacroChem Announces Departure of CEO Robert Palmisano & Appointment of Board Member Robert J. Deluccia as Vice Chairman & Interim CEO	Immunomedics, Inc.	MacroChem Corp.
$52	Subscribers Preview	2004	Purchase Agreement	Immunomedics; BNY; Bear, Stearns	Fleet National; Cadwalader
$61	Subscribers Preview	2005	Purchase Agreement	Immunomedics, Inc.	JPMorgan Chase Bank
$47	Subscribers Preview	2004	Registration Rights Agreement	Immunomedics; BNY	Bear, Stearns
$56	Subscribers Preview	2005	Registration Rights Agreement	Immunomedics, Inc.	Cadwalader, Wickersham & Taft
$68	Subscribers Preview	2002	Share Purchase Agreement	State of Wisconsin Investment Board; AMI; Cytogen	Draxis Health 2 3 4 5
$39	Subscribers	2002	Statement of Control Person	Immunomedics, Inc.
$62	Subscribers Preview	2004	Termination Agreement	Amgen; Immunomedics	Heller Ehrman
$34	Subscribers Preview	2001	The Medicines Company Strengthens Senior Management Team	Immunomedics, Inc.	Medicines Co.